Correction b5: the device was filled with daptomycin 850mg in a total volume of 100ml.The issue was identified after being filled during post compounding inspection (omitted on initial report).H4: the device was manufactured from september 27, 2022 - september 28, 2022.H10: the actual device was not available; however, photographs of the sample were provided for evaluation.Upon visual inspection of the photographs, evidence of loose lower film-wrap was observed.The reported condition was verified.The cause of the condition was determined to be an assembly related issue during the manufacturing process.A batch review was conducted and there were no deviations found related to this reported condition during the manufacture of this lot.Should additional relevant information become available, a supplemental report will be submitted.
|